GenExDividendInvestor (@genexdividend) 's Twitter Profile
GenExDividendInvestor

@genexdividend

Retired via dividends. Sharing my 30+ yr investing insights on YouTube 80k subs & on the world's largest Dividend Discord discord.gg/kkSr5FY 11k subs.

ID: 1162815470648512512

linkhttps://www.youtube.com/c/GenExDividendInvestor?sub_confirmation=1 calendar_today17-08-2019 19:56:50

3,3K Tweet

8,8K Followers

31 Following

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Altria (6.59% of my portfolio is $MO) may be announcing a hike to their #dividend relatively soon. If they do then how much do you guess it will increase on a % basis?

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

In this episode, I’ll walk you through 9 strengths of quality dividend stocks that even the skeptics can’t realistically refute. And to keep things balanced, I’ll also break down the common counterarguments critics would probably bring up, so you get a well-rounded perspective.

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Procter & Gamble (3.56% of my portfolio is $PG) beats on GAAP EPS of $1.48 vs $1.41 and on revenue of $20.9B vs $20.84B. They warned earnings will take a $1 billion hit in its new fiscal year as a result of tariffs and named the new CEO (their current COO). They returned over

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Amplify CWP Enhanced Dividend Income ETF (4.48% of my portfolio is $DIVO) announces a 7/31 dividend distribution payout of $0.17244/shr raising their TTM by 0.71%. IDVO's (1.13% of my port) will be $0.17055/shr raising their TTM by 0.89%.

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Altria (6.63% of my portfolio is $MO) beats on non-GAAP EPS of $1.44 vs $1.38 and beats on revenue of $6.1B vs $5.19B and raises the lower-end of their 2025 full-year guidance. They returned more than $4B of dividends and share buybacks during the 1st half of the year.

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Starbucks (0.85% of my portfolio is $SBUX) misses on non-GAAP EPS of $0.50 vs $0.65 but beats on revenue of $9.46B vs $9.31B. Margins tightening under turnaround investments. investor.starbucks.com/news/financial…

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Microsoft (5.65% of my portfolio is $MSFT) beats on GAAP EPS of $3.65 vs $3.38 and on revenue of $76.4B vs $73.84B. They returned $9.4B to shareholders through dividends and buybacks in Q4 FY25. microsoft.com/en-us/investor…

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Southern Co (3.14% of my portfolio is $SO) beats on non-GAAP $0.92 beats vs $0.88 and beats on revenue of $6.97B vs $6.4B. southerncompany.mediaroom.com/2025-07-31-Sou…

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

AbbVie (5.33% of my portfolio is $ABBV) beats on non-GAAP EPS of $2.97 vs $2.91 and beats on revenue of $15.42B vs $15.03B and raises EPS outlook. investors.abbvie.com/news-releases/…

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Apple (2.5% of my portfolio is $AAPL) beats on GAAP EPS of $1.57 vs $1.43 and beats on revenue of $94.04B vs $89.16B. apple.com/newsroom/2025/…

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

JPMorgan Nasdaq Equity Premium Income ETF (4.27% of my portfolio is $JEPQ) announces their August distribution #dividend of $0.44377/shr/mo, payable on 8/5/25, which raises their TTM to $6.19505 am.jpmorgan.com/us/en/asset-ma…

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Colgate-Palmolive (1.64% of my portfolio is $CL) beats on non-GAAP EPS of $0.92 vs $0.89 and beats on revenue of $5.11B vs $5.03B. investor.colgatepalmolive.com/news-releases/…

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Kimberly-Clark (2.14% of my portfolio is $KMB) beats on non-GAAP EPS of $1.92 vs $1.67, misses on revenue of $4.16B vs $4.61B, but raises 2025 outlook. investor.kimberly-clark.com/2025-08-01-Kim…

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

In this episode, I’ll go over each of the dividend stocks in my multi-million dollar portfolio and share whether I believe them to be undervalued, fairly priced, or overvalued, which may help inform your own research as you decide whether now is the time to buy, hold, or sell.

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Caterpillar (2.64% of my portfolio is $CAT) misses on non-GAAP EPS of $4.72 vs $4.90 but beats on revenue of $16.6B vs $16.26B. In the quarter, CAT deployed $0.8B for repurchases & $0.7B for dividends. caterpillar.com/en/news/corpor…

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Duke Energy (3.96% of my portfolio is $DUK) beats on non-GAAP EPS of $1.25 vs $1.19 and beats on revenue of $7.51B vs $7.47B. s201.q4cdn.com/583395453/file…

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

McDonald's (3.59% of my portfolio is $MCD) beats on Non-GAAP EPS of $3.19 vs $3.15 and beats on revenue of $6.84B vs $6.7B. I'm lovin' it! corporate.mcdonalds.com/content/dam/si…

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

Realty Income (6.3% of my portfolio is $O) reported Q2 AFFO of $1.05/share, in line with estimates. Revenue beat at $1.41B vs ~$1.402B consensus. FY25 AFFO guidance raised to $4.24–$4.28/share (vs $4.26 consensus). Occupancy rose to 98.6% (up from 98.5% in Q1).

GenExDividendInvestor (@genexdividend) 's Twitter Profile Photo

In this episode, I’ll tell you how I unexpectedly woke up in a hospital recovery room and how that pushed me to consider some changes to my dividend portfolio, changes I’d really like to get your feedback on. Follow for #investing insights about #dividend stocks!